verapamil has been researched along with Cardio-Renal Syndrome in 1 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Cardio-Renal Syndrome: Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil is a non-dihydropyridine calcium channel blocker (CCB) widely used in the treatment of hypertension, chronic stable angina, secondary prevention of reinfarction, paroxysmal supra-ventricular tachycardia and for rate control in atrial fibrillation/flutter." | 6.82 | Verapamil: prevention and treatment of cardio-renal syndromes in diabetic hypertensive patients? ( Bei, A; Calò, L; Cice, G; Di Lullo, L; Lido, P; Noce, A; Palazzetti, D; Perrone, MA; Romanello, D; Tesauro, M, 2022) |
| "Verapamil is a non-dihydropyridine calcium channel blocker (CCB) widely used in the treatment of hypertension, chronic stable angina, secondary prevention of reinfarction, paroxysmal supra-ventricular tachycardia and for rate control in atrial fibrillation/flutter." | 2.82 | Verapamil: prevention and treatment of cardio-renal syndromes in diabetic hypertensive patients? ( Bei, A; Calò, L; Cice, G; Di Lullo, L; Lido, P; Noce, A; Palazzetti, D; Perrone, MA; Romanello, D; Tesauro, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lido, P | 1 |
| Romanello, D | 1 |
| Tesauro, M | 1 |
| Bei, A | 1 |
| Perrone, MA | 1 |
| Palazzetti, D | 1 |
| Noce, A | 1 |
| Di Lullo, L | 1 |
| Calò, L | 1 |
| Cice, G | 1 |
1 review available for verapamil and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Verapamil: prevention and treatment of cardio-renal syndromes in diabetic hypertensive patients?
Topics: Cardio-Renal Syndrome; Diabetes Mellitus; Diabetic Nephropathies; Female; Heart Failure; Humans; Hyp | 2022 |